Omron (OTCMKTS:OMRNY) Reaches New 12-Month High Following Analyst Upgrade

Omron Corp. (OTCMKTS:OMRNY) reached a new 52-week high during mid-day trading on Tuesday after Zacks Research upgraded the stock from a strong sell rating to a hold rating. The stock traded as high as $43.48 and last traded at $43.4350, with a volume of 3277 shares. The stock had previously closed at $42.21.

Separately, Jefferies Financial Group lowered shares of Omron from a “buy” rating to a “hold” rating in a research report on Tuesday, June 16th. Two analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock has a consensus rating of “Hold”.

Omron Trading Up 2.8%

The company has a current ratio of 1.83, a quick ratio of 1.41 and a debt-to-equity ratio of 0.08. The stock has a market capitalization of $8.74 billion, a P/E ratio of 42.32, a P/E/G ratio of 0.64 and a beta of 1.14. The business’s fifty day simple moving average is $35.99 and its two-hundred day simple moving average is $33.13.

Omron Company Profile

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.